May 31, 2017
Boston Healthcare Associates and Data Information Intelligence Announce Global Life Sciences Data Commercialization Partnership. Click here to read more.

April 5, 2017
Research by Boston Healthcare highlights new data demonstrating increased value from innovative biopharmaceutical treatments for Rheumatoid Arthritis. Click here to read more.

June 23, 2015
Boston Healthcare releases latest white paper in the PhRMA-sponsored series focused on recognizing value in biopharmaceutical innovation, The Value of Innovation in Oncology: Recognizing Emerging Benefits Over Time. Click here to read the press release.

March 4, 2015
Boston Healthcare instrumental in developing tools to estimate the cost and value of next-generation sequencing (NGS) for the Association for Molecular Pathology (AMP). AMP recently released these health economic evaluation tools for genome sequencing procedure CPT codes including a micro-costing analysis template tool that molecular diagnostic laboratories can use to calculate the cost of their next-generation sequencing assays used to perform these procedures. Also three health economic models, including customized models for whole exome analysis, tumor panel for non-small cell lung cancer (NSCLC), and hearing loss are now available to help demonstrate the economic value of NGS procedures. Click here to read the AMP press release. Click here for access to the AMP models and to view a webinar describing the projects.

November 18, 2014
As featured in Medical Design Technology magazine, Boston Healthcare participates in first annual Parker Human Motion Summit which focused on industry perspectives for demonstrating the value of innovative neurorehabilitation technologies. Leading practitioners, executives, and payment policy makers gathered for insightful panel discussions and debates on topics ranging from clinician experiences utilizing new devices and techniques in rehabilitation programs, to hospital administrator insights into purchasing and decision making processes for early adoption, and to payment policy makers perspectives on reimbursement for emerging neurorehabilitation products in the clinic and the home. >>

September 10, 2014
Boston Healthcare releases new white paper, The Value of Innovation in HIV/AIDS Therapy, as part of PhRMA-sponsored series focused on recognizing value in biopharmaceutical innovation.

May 12, 2014
Boston Healthcare’s Charles Mathews, Vice President, contributes to Medical Device + Diagnostic Industry (MD+DI) magazine. The blog post was featured in a quarterly IVD-focused MD+DI e-newsletter. Please click here to read the post.

March/April 2014
Boston Healthcare survey recently published in the March/April issue of the Journal of the Association of Community Cancer Centers – Oncology Issues. The report, “Physician Survey of Impact of Payer Policies on Medically Appropriate Off-Label Use” was a collaboration between the Association of Community Cancer Centers (ACCC), the Biotechnology Industry Organization (BIO), Boston Healthcare, and Pharmaceutical Research and Manufacturers of America (PhRMA). Please contact Boston Healthcare at for more information.

January 15, 2014
Boston Healthcare’s Joseph V. Ferrara, President, featured panel participant at the OneMedForum / 32nd J.P. Morgan Healthcare Conference – Medical Device Daily >>

January 14, 2014
Boston Healthcare’s Betty Su, Vice President, Asia-Pacific contributes insight to the British Medical Journal (BMJ) for the article, “China to Blacklist Wayward Drug Manufacturers.” For a summary of the article or for more information, contact To purchase the article, click here.

December 17, 2013
As part of the European Personalized Medicine Association’s (EPEMED) 2013 Year-End Webinar Series devoted to market access, Boston Healthcare’s Joseph V. Ferrara, President, discusses changes in the global health care funding and innovation environment and also how pharmaceutical and diagnostic companies can deliver increased value demanded by providers, payers, and patients. Click here to download Joseph Ferrara’s webinar, “Global Commercialization of Companion Diagnostics: Value Capture in Personalized Medicine.”

October 26-31, 2013
Boston Healthcare’s Thomas F. Goss, Senior Vice President, and Jyoti Aggarwal, Director, contribute to design and data analysis of award winning abstract. The American College of Chest Physicians’ (CHEST) Foundation and Scientific Presentation and Awards Committee presented the Alfred Soffer Research Award to Nichole Tanner, MD, lead author of the abstract, for outstanding original scientific research in “A Multicenter, Community-Based Chart Review of the Evaluation and Management of Lung Nodules by Pulmonologists.” Click here for access to the abstract.

April 3, 2013
Boston Healthcare contributes guest post in PhRMA’s Catalyst Blog >>

March 20, 2013
Third report in Boston Healthcare’s “Recognizing the Value of Innovation” series released today; highlights Rheumatoid Arthritis treatment >>

January 7, 2013
Boston Healthcare quoted in recent “The Gray Sheet” article on health reform and leadership transitions in China >>

November 30, 2012
Boston Healthcare contributes guest post in PhRMA’s Catalyst Blog >>

November 29, 2012
Boston Healthcare White Paper Highlights Value of Innovation in Relation to HIV/AIDS Therapy >>

November 27, 2012
Boston Healthcare Expands Health Economics, Pricing, and Reimbursement Consulting Practice in Asia >>